Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ

Anthony G. Doyle, Georges Herbein, Luis J. Montaner, Adrian J. Minty, Daniel Caput, Pascual Ferrara, Siamon Gordon*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

258 Scopus citations


Interleukin (IL)‐13 is a newly described cytokine expressed by activated lymphocytes. We examined the effects of the murine recombinant cytokine on the phenotype and activation status of elicited peritoneal macrophages (Mϕ), concentrating on activities which are known to be modulated by interferon‐γ and IL‐4. IL‐13 markedly suppressed nitric oxide release and to a lesser extent secretion of the pro‐inflammatory cytokine tumor necrosis factor‐α. However, antimicrobial capacity was not completely jeopardized as the respiratory burst was unaffected, and indeed the enhanced expression of Mϕ mannose receptor and major histocompatibility class II, and regulation of sialoadhesin, the Mϕ sialic acid‐specific receptor involved in hemopoietic and lymphoid interactions, suggest that these cells are not simply deactivated, but primed for an active role in immune and inflammatory responses. These activities closely mimic those of IL‐4, but mediation of the effects by IL‐4 was discounted by the use of a neutralizing monoclonal antibody. Thus, IL‐13, like IL‐4, is a cytokine which has complex effects on Mϕ behavior, inducing activities characteristic of both activation and deactivation.

Original languageEnglish
Pages (from-to)1441-1445
Number of pages5
JournalEuropean Journal of Immunology
Issue number6
StatePublished - 06 1994
Externally publishedYes


  • Cytokines
  • Interleukin‐13
  • Interleukin‐4
  • Macrophages
  • Th2 lymphocytes


Dive into the research topics of 'Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ'. Together they form a unique fingerprint.

Cite this